Literature DB >> 8633580

Clinical features of type III (mixed) paraesophageal hernia.

J M Wo1, G D Branum, J G Hunter, T N Trus, S J Mauren, J P Waring.   

Abstract

OBJECTIVES: The clinical presentation of patients with a paraesophageal hernia is poorly understood. The aim of this study was to evaluate the progression of symptoms in patients with type III paraesophageal hernia.
METHODS: We evaluated 25 patients (mean age 66 yr) with a type III paraesophageal hernia, who then had laparoscopic surgical repair. The patients characterized their symptoms as 1) chronic or 2) prompting evaluation (progressive or new). We defined postprandial distress as chest or epigastric pain, shortness of breath, or nausea or vomiting during or shortly after meals.
RESULTS: We identified three distinct types of chronic symptoms: heartburn only (36%), heartburn and postprandial distress (32%), and postprandial distress only (32%). Twenty-three patients (92%) reported postprandial distress as the symptom prompting evaluation compared with only 10 patients (40%) reporting heartburn. Eight patients (32%) never had heartburn. Postprandial distress was their only symptom. Laparoscopic repair of the paraesophageal hernia resolved postprandial distress in 74% and improved symptoms in the remaining 26% of patients (mean follow-up 12 months).
CONCLUSIONS: Post-prandial distress is the most prominent symptom in patients with a type III paraesophageal hernia. Most patients had chronic symptoms of a sliding hiatal hernia but later featured more pronounced postprandial distress. However, one-third of the patients never experienced significant heartburn. A type III paraesophageal hernia should be suspected in patients, with or without heartburn, who develop new or progressive symptoms of postprandial distress.

Entities:  

Mesh:

Year:  1996        PMID: 8633580

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  Long-term outcome of laparoscopic antireflux surgery in the elderly.

Authors:  Olivier Brehant; Patrick Pessaux; Jean-Pierre Arnaud; Jean-François Delattre; Christian Meyer; Jacques Baulieux; Henri Mosnier
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

2.  Laparoscopic management of totally intra-thoracic stomach with chronic volvulus.

Authors:  Toygar Toydemir; Gökhan Çipe; Oğuzhan Karatepe; Mehmet Ali Yerdel
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

3.  Treatment of older patients with hiatal hernia.

Authors:  John M Wo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-02

Review 4.  Paraesophageal Hernia and Reflux Prevention: Is One Fundoplication Better than the Other?

Authors:  Ciro Andolfi; Alejandro Plana; Sara Furno; Piero Marco Fisichella
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

5.  The integrity of esophagogastric junction anatomy in patients with isolated laryngopharyngeal reflux symptoms.

Authors:  Kyle A Perry; C Kristian Enestvedt; Cedric S F Lorenzo; Paul Schipper; Joshua Schindler; Cynthia D Morris; Katie Nason; James D Luketich; John G Hunter; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2008-08-02       Impact factor: 3.452

6.  Complications of laparoscopic paraesophageal hernia repair.

Authors:  T L Trus; T Bax; W S Richardson; G D Branum; S J Mauren; L L Swanstrom; J G Hunter
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

7.  Tailored or routine addition of an antireflux fundoplication in laparoscopic large hiatal hernia repair: a comparative cohort study.

Authors:  Edgar J B Furnée; Werner A Draaisma; Hein G Gooszen; Eric J Hazebroek; Andre J P M Smout; Ivo A M J Broeders
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

Review 8.  Paraesophageal hernia: to fundoplicate or not?

Authors:  Daniel Solomon; Eliahu Bekhor; Hanoch Kashtan
Journal:  Ann Transl Med       Date:  2021-05

9.  Management of acute upside-down stomach.

Authors:  Tobias S Schiergens; Michael N Thomas; Thomas P Hüttl; Wolfgang E Thasler
Journal:  BMC Surg       Date:  2013-11-15       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.